Generated effect modifiers (GEM's) in randomized clinical trials.

In a randomized clinical trial (RCT), it is often of interest not only to estimate the effect of various treatments on the outcome, but also to determine whether any patient characteristic has a different relationship with the outcome, depending on treatment. In regression models for the outcome, if there is a non-zero interaction between treatment and a predictor, that predictor is called an "effect modifier". Identification of such effect modifiers is crucial as we move towards precision medicine, that is, optimizing individual treatment assignment based on patient measurements assessed when presenting for treatment. In most settings, there will be several baseline predictor variables that could potentially modify the treatment effects. This article proposes optimal methods of constructing a composite variable (defined as a linear combination of pre-treatment patient characteristics) in order to generate an effect modifier in an RCT setting. Several criteria are considered for generating effect modifiers and their performance is studied via simulations. An example from a RCT is provided for illustration.

[1]  Margaret Sullivan Pepe,et al.  Evaluating Markers for Selecting a Patient's Treatment , 2004, Biometrics.

[2]  Lacey Gunter,et al.  Variable Selection for Qualitative Interactions in Personalized Medicine While Controlling the Family-Wise Error Rate , 2011, Journal of biopharmaceutical statistics.

[3]  J. Robins,et al.  Estimation of Regression Coefficients When Some Regressors are not Always Observed , 1994 .

[4]  Lu Tian,et al.  Adaptive index models for marker-based risk stratification. , 2011, Biostatistics.

[5]  Min Zhang,et al.  Estimating optimal treatment regimes from a classification perspective , 2012, Stat.

[6]  Ian W McKeague,et al.  Estimation of treatment policies based on functional predictors. , 2014, Statistica Sinica.

[7]  S. Wellek Testing for Absence of Qualitative Interactions Between Risk Factors and Treatment Effects , 1997 .

[8]  John W. Tukey,et al.  Use of many covariates in clinical trials , 1991 .

[9]  Eric B. Laber,et al.  Tree-based methods for individualized treatment regimes. , 2015, Biometrika.

[10]  D A Follmann,et al.  A Multivariate Test of Interaction for Use in Clinical Trials , 1999, Biometrics.

[11]  Eva Petkova,et al.  Treatment decisions based on scalar and functional baseline covariates , 2015, Biometrics.

[12]  J. Robins,et al.  Estimation and extrapolation of optimal treatment and testing strategies , 2008, Statistics in medicine.

[13]  James M. Robins,et al.  Optimal Structural Nested Models for Optimal Sequential Decisions , 2004 .

[14]  Donglin Zeng,et al.  Estimating Individualized Treatment Rules Using Outcome Weighted Learning , 2012, Journal of the American Statistical Association.

[15]  Donglin Zeng,et al.  On sparse representation for optimal individualized treatment selection with penalized outcome weighted learning , 2015, Stat.

[16]  S. Murphy,et al.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES. , 2011, Annals of statistics.

[17]  S. Murphy,et al.  Optimal dynamic treatment regimes , 2003 .

[18]  J. Tukey Tightening the clinical trial. , 1993, Controlled clinical trials.

[19]  M. Gail,et al.  Testing for qualitative interactions between treatment effects and patient subsets. , 1985, Biometrics.

[20]  Hsuan-Yu Chen,et al.  Survival Prediction Based on Compound Covariate under Cox Proportional Hazard Models , 2012, PloS one.

[21]  Eric B. Laber,et al.  A Robust Method for Estimating Optimal Treatment Regimes , 2012, Biometrics.

[22]  Wenbin Lu,et al.  Variable selection for optimal treatment decision , 2013, Statistical methods in medical research.

[23]  Holly Janes,et al.  Combining biomarkers to optimize patient treatment recommendations , 2014, Biometrics.

[24]  J. Ware,et al.  Detecting Moderator Effects Using Subgroup Analyses , 2013, Prevention Science.

[25]  D. Schoenfeld,et al.  Detecting treatment‐covariate interactions using permutation methods , 2015, Statistics in medicine.

[26]  Donglin Zeng,et al.  New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes , 2015, Journal of the American Statistical Association.

[27]  Helena Chmura Kraemer,et al.  Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach , 2013, Statistics in medicine.